UPDF AI

Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.

J. Riba,P. Anderer,4 Authors,M. Barbanoj

2002 · DOI: 10.1046/J.1365-2125.2002.01609.X
British Journal of Clinical Pharmacology · 135 Citations

TLDR

The q-EEG profile supports the role of 5-HT2 and dopamine D2-receptor agonism in mediating the effects of ayahuasca on the central nervous system, and shows a time pattern which closely paralleled that of previously reported subjective effects.